Document is current

Any future updates will be listed below

MET-amplifiziertes NSCLC: Neue Option nach EGFR-TKI-Therapie

Crossref DOI link: https://doi.org/10.1007/s15004-025-1040-8

Published Online: 2025-07-25

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark